Proxima Research and Development is a biopharma and biotechnology startup based in Canada, founded in 2021. The company's slogan "Perfecting the art of good science" encapsulates its mission of providing scalable and customizable scientific services with an emphasis on affordability and accessibility for small and medium enterprises. Proxima's innovative approach to contract research and scientific services focuses on applied biotechnology, catering to academic and industrial scientists in various fields including bioproducts, pharmaceuticals, biofuels, food, crop development, and pure research. In January 15, 2024, Proxima secured Seed Round investment from the Global Agri-Food Advancement Partnership, signifying an endorsement of its potential in the scientific services space. The investment is expected to fuel Proxima's expansion and the development of new scientific service offerings. With a diverse range of services including custom reagents, vector and protein services, assay development, and biochemical and technical services, Proxima Research and Development is poised to make a significant impact on the biopharma and biotechnology industries.
No recent news or press coverage available for Proxima Research and Development.